Type 2 Diabetes Mellitus (T2DM)Obesity (Disorder)OverweightMetabolic Syndrome
The goal of this clinical trial is to learn whether the NutriSteppe mobile application can improve blood sugar control a…
Almaty, KazakhstanEst. completion Nov 2026
Obesity & Overweight
This study investigates the Topical-Lingual (T-L) delivery of semaglutide, a GLP-1 receptor agonist (GLP-1RA), via an or…
Minneapolis, United StatesEst. completion May 2027
ObesityDiabetes Type 2
Overweight/obese otherwise healthy volunteers will be recruited from the Old Order Amish population in Lancaster County,…
Lancaster, United StatesEst. completion Apr 30, 2027
Chronic Kidney DiseasesObesity
* Prolonged sitting (sedentary behavior) is a risk factor for decreased kidney function, obesity, diabetes and mortality…
Stanford, United StatesEst. completion Dec 31, 2026
Healthy
This is a Phase 1, randomized, double-blind, placebo-controlled, single-center study designed to evaluate the safety, to…
Brisbane, AustraliaEst. completion Dec 24, 2026
HealthyBrain Insulin SensitivityCerebral Blood FlowBrain Vascular FunctionSatiety and Food IntakeFood RewardCognitive PerformanceAbdominal ObesityCognitive Decline
Rationale: Healthy foods, including mixed nuts, may improve brain function, which is essential for cognitive and metabol…
Maastricht, NetherlandsEst. completion Aug 2027
Atherosclerotic Cardiovascular DiseaseOverweightObesity
The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as …
Daphne, United StatesEst. completion Jun 30, 2028
Obesity & OverweightPerimenopausal WomenPrebioticsInulinMuscle, SkeletalCardiovascular Diseases (CVD)MicrobiotaGastrointestinal MicrobiomeDietary FiberWomen HealthVascular HealthInsulin Resistance
This study aims to evaluate the effects of 2 weeks of inulin supplementation in perimenopausal women with overweight or …
Washington D.C., United StatesEst. completion Feb 2028
HealthyObesity
Part 1:
To investigate safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of BI 3034701 in Japanese …
Fukuoka, Fukuoka, JapanEst. completion Dec 22, 2026
Bariatric Surgery and Physical ActivityObesity/TherapyBariatric Surgery ComplicationsBariatric Patients
The goal of this clinical trial is to see the impact of a physical exercise programme and respiratory physiotherapy befo…
Vigo, SpainEst. completion Sep 30, 2028
ObesitySkin DiseaseCancerHIVDiabetesChronic Pain
Stigma due to health conditions increases disease burden and adversely impacts health. The internalization of health-rel…
Gainesville, United StatesEst. completion Dec 31, 2026
Adults With Overweight/Obesity and Type 2 Diabetes
The goal of this clinical trial is to learn if AT673 contributes to additional weight loss and glycemic control when giv…
Chandler, United StatesEst. completion Feb 2027
Obesity & OverweightDiabetes (DM)
This study examines how adults who take a GLP-1 receptor agonist medication (such as semaglutide \[Ozempic, Wegovy, Rybe…
Columbus, United StatesEst. completion Oct 2026
Knee OsteoarthristisDiabetes (DM)Obesity & OverweightChronic Kidney Disease
This study recruits patients with coexisting obesity and knee osteoarthritis (KOA) to implement the NTU-JO Smart Program…
Taipei, TaiwanEst. completion Dec 31, 2029
Osteoarthritis, Knee
The goal of this study is to establish the efficacy of an intervention of dietary weight loss, exercise, and weight-loss…
Boston, United StatesEst. completion Jul 31, 2029
ObesityHealthy Volunteers
This study will describe the phenotype (physical and behavioral traits) of overweight and obese people. It will characte…
Bethesda, United States
ObesityOverweight
This study is open to adults between 18 and 74 years of age and who have a body mass index (BMI) of 30 kg/m2 or more, or…
Birmingham, United StatesEst. completion Aug 4, 2027
Breast Cancer Females
The goal of this clinical trial is to evaluate whether a 3-month dance-based exercise program combined with individualiz…
Bratislava, SlovakiaEst. completion Mar 1, 2026
Obesity
This is a first in human, randomized, double-blind (DB), placebo-controlled, single ascending dose (SAD), Phase 1 study …
Mount Royal, CanadaEst. completion Dec 14, 2027
ObesityOverweight
The primary objective of this study is to determine the efficacy of oral KAI-7535 once daily compared with placebo on pe…
Chandler, United StatesEst. completion Jul 7, 2027